CO141 Assessing the Impact of Additional Follow-up Data on Disease-Free Survival (DFS) Projections of Nivolumab and Surveillance in High-Risk, Muscle-Invasive Urothelial Carcinoma (MIUC) Patients Within the CheckMate-274 Trial
Abstract
Authors
T. Chandler I. Orsini C. Van Beurden-Tan M. Kurt M. Patel S. Teitsson